Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-143047
Filing Date
2012-03-30
Accepted
2012-03-30 14:12:02
Documents
8
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d324048d10k.htm 10-K 1334456
2 SUBSIDIARIES OF THE REGISTRANT d324048dex211.htm EX-21.1 2058
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d324048dex231.htm EX-23.1 1794
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d324048dex311.htm EX-31.1 5935
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d324048dex312.htm EX-31.2 5910
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 d324048dex321.htm EX-32.1 3903
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 d324048dex322.htm EX-32.2 3863
8 GRAPHIC g324048g27r31.jpg GRAPHIC 71020
  Complete submission text file 0001193125-12-143047.txt   1456891
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35420 | Film No.: 12728006
SIC: 2834 Pharmaceutical Preparations